Skip to main content
Kathleen Mullin, MD, Neurology, Stamford, CT

KathleenBMullinMD

Neurology Stamford, CT

Headache

Neurology at Mount Sinai

Dr. Mullin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mullin's full profile

Already have an account?

  • Office

    30 Buxton Farm Rd
    Ste 230
    Stamford, CT 06905
    Phone+1 203-914-1900
    Fax+1 203-914-1903

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2008 - 2011
  • Westchester Medical Center
    Westchester Medical CenterInternship, Internal Medicine, 2007 - 2008
  • New York University School of Medicine
    New York University School of MedicineClass of 2007

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2008 - 2025
  • American Board of Psychiatry and Neurology Neurology
  • United Council for Neurologic SubspecialtiesHeadache Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Lectures

  • Headache in Children: Identification and Management 
    Icahn School of Medicine at Mount Sinai, New York, New York - 4/20/2013

Press Mentions

  • Zavzpret (Zavegepant) Migraine Nasal Spray from Pfizer Gets FDA Nod
    Zavzpret (Zavegepant) Migraine Nasal Spray from Pfizer Gets FDA NodMarch 14th, 2023
  • Migraine Nasal Spray from Pfizer Snags FDA Approval for Expected Summer Launch
    Migraine Nasal Spray from Pfizer Snags FDA Approval for Expected Summer LaunchMarch 11th, 2023
  • FDA Approves a New Nasal Spray to Treat Migraines
    FDA Approves a New Nasal Spray to Treat MigrainesMarch 10th, 2023
  • Join now to see all